Alnylam’s drug, vutrisiran, was approved for patients with transthyretin amyloid cardiomyopathy, or ATTR-CM, to reduce ...
U.S. President Donald Trump on Friday signed an executive order directing the heads of government agencies to grant federal ...
Researchers, executives, and thought leaders across healthcare gathered at NVIDIA GTC to discuss today’s pressing AI life science applications.
Vast quantities of climate and environmental information have been removed from official websites in the past months.
A new tool about chemical contaminants in human and animal foods is available from the FDA. The Chemical Contaminants Transparency Tool is the latest ...
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...
The FDA unveiled the Chemical Contaminants Transparency Tool, a searchable online database that provides a list of chemical contaminant types and levels used to evaluate possible harm in foods meant ...
The U.S. Food and Drug Administration on Thursday launched an online searchable database listing contaminant levels in human ...
The state's insurance regulator has been seeking such information as patient names, dates of birth and prescription details.
UnitedHealth Group's pharmacy business, Optum Rx, said it is eliminating up to 25% of reauthorizations for prescription drugs to simplify access for consumers.
Biotech company Valo Health and AI healthcare firm nference have entered into a multi-year partnership to leverage AI and ...
BD, Medtronic and Abbott were among the top 10 device companies with the highest number of late reports to the FDA, the study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results